Medpace Holdings Inc.
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
48.58%
Market Cap
-
P/E Ratio
36.76
Dividend Yield
0.00 %
Earnings per Share
13.54 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 380.8 G | 0 Units |
| PRICE DETERMINATION TIME | 06/04/2026 / 08:03:11 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 380.8 | 380.6 |
| PREV. DAY'S PRICE | 388.4 | (06/03) |
| CHANGE DAY BEFORE | -7.60 | -1.96 % |
| 52 WEEK HIGH / LOW | 558.2 (10/23) | 257.2 (06/18) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 15.73 | 14.53 | 13.54 | 11.68 | 8.21 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 24.41 | 26.44 | 36.76 | 26.30 | 34.53 |
| PRICE - BOOK RATIO | - | - | 34.63 | 12.30 | 16.83 |
| PRICE - SALES RATIO | - | - | 6.55 | 5.04 | 5.18 |
| PRICE - CASH FLOW RATIO | - | - | 23.25 | 17.47 | 22.52 |
Master Data
| WKN | A2APTV |
| ISIN | US58506Q1094 |
| SYMBOL | 01P |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | MEDPACE HOLDINGS DL-,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 5.51 % | 8.98 % | -2.63 % | -21.79 % | 48.58 % | 96.36 % | 181.45 % | -19.20 % |
| HIGH | 393.50 | 393.50 | 447.90 | 537.80 | 558.20 | 558.20 | 558.20 | 537.80 |
| LOW | 360.00 | 345.60 | 334.00 | 334.00 | 257.20 | 192.00 | 118.00 | 334.00 |
Dividend
per share
MEDPACE HOLDINGS DL-,01 does not deliver dividend information
Company profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Structured products for Medpace Holdings Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.